HCC
CSII

Hirtle Callaghan & Co’s Cardiovascular Systems, Inc. CSII Stock Holding History

Hirtle Callaghan & Co’s Portfolio CSII Stock Details CSII Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-2,600
Closed -$78K – 387
2014
Q4 		$78K Hold
2,600
– – 0.02% 256
2014
Q3 		$61K Hold
2,600
– – 0.01% 285
2014
Q2 		$81K Hold
2,600
– – 0.01% 308
2014
Q1 		$83K Hold
2,600
– – 0.01% 303
2013
Q4 		$89K Hold
2,600
– – 0.01% 280
2013
Q3 		$52K Buy
+2,600
New +$54.1K 0.01% 336

Other funds holding CSII

CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
NCGI
Next Century Growth Investors Plymouth, Minnesota $1.38B AUM 102.34% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Hirtle Callaghan & Co's CSII Position: Q1 2015 in Review

Hirtle Callaghan & Co sold out of Cardiovascular Systems, Inc. (CSII) in Q1 2015, closing a stake of 2,600 shares — an estimated $78K sold.

Hirtle Callaghan & Co first reported a position in CSII in Q3 2013 and held it in 6 quarters. The position peaked at $89K in Q4 2013. 135 funds tracked by Wall St. Rank hold CSII as of Q1 2015.

  • Hirtle Callaghan & Co reported no remaining Cardiovascular Systems, Inc. position as of Q1 2015 after selling out during the quarter.
  • Hirtle Callaghan & Co sold 2,600 Cardiovascular Systems, Inc. shares in Q1 2015, an estimated $78K.
  • Hirtle Callaghan & Co first reported a position in Cardiovascular Systems, Inc. in Q3 2013 and held it in 6 quarters.
  • Hirtle Callaghan & Co's Cardiovascular Systems, Inc. position peaked at $89K in Q4 2013.
  • 135 funds tracked by Wall St. Rank held Cardiovascular Systems, Inc. as of Q1 2015.

Based on Hirtle Callaghan & Co's 13F filing for Q1 2015, filed 15 May 2015.